{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:22:47Z","timestamp":1790997767068,"version":"4.1.0"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["DK103804"],"award-info":[{"award-number":["DK103804"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.physbeh.2016.02.034","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T18:45:25Z","timestamp":1456685125000},"page":"130-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Amylin-mediated control of glycemia, energy balance, and cognition"],"prefix":"10.1016","volume":"162","author":[{"given":"Elizabeth G.","family":"Mietlicki-Baase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2016.02.034_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes melutus","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0010","unstructured":"Ehrlich, J.C, Ratner, I.M. Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals. Am. J. Pathol. 1961,38:49\u201359."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00432160","article-title":"Amyloid of human islets of Langerhans. II. Electron microscopic analysis of isolated amyloid","volume":"373","author":"Westermark","year":"1977","journal-title":"Virchows Arch. A Pathol. Anat. Histol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0020","first-page":"191","article-title":"Spontaneous diabetes mellitus in Macaca cyclopis and Mandrillus leucophaeus: case reports","volume":"25","author":"Howard","year":"1975","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/diab.27.4.357","article-title":"Insular amyloidosis and diabetes mellitus in Macaca nigra","volume":"27","author":"Howard","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/diab.22.2.81","article-title":"Light and electron microscopic studies of islet amyloid in diabetic cats","volume":"22","author":"Johnson","year":"1973","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/030098588101800507","article-title":"Feline insular amyloid: association with diabetes mellitus","volume":"18","author":"Yano","year":"1981","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0040","first-page":"414","article-title":"Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone","volume":"127","author":"Westermark","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0045","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0050","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0055","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","article-title":"The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells","volume":"273","author":"Konarkowska","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0065","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"Cooper","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","article-title":"Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro","volume":"335","author":"Leighton","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/338211a0","article-title":"\u2018Amylin\u2019 hormone","volume":"338","author":"Betsholtz","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1054-3589(05)52004-0","article-title":"Amylin and the integrated control of nutrient influx","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0029-1211958","article-title":"The role of amylin in the physiology of glycemic control","volume":"106","author":"Scherbaum","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0095","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","article-title":"Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment","volume":"85","author":"Ogawa","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(90)80210-A","article-title":"Cosecretion of amylin and insulin from isolated rat pancreas","volume":"262","author":"Fehmann","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/diab.39.5.639","article-title":"Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration","volume":"39","author":"Mitsukawa","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-291X(90)90389-5","article-title":"Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation","volume":"169","author":"Nakazato","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0120","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1517\/13543784.10.9.1641","article-title":"Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus","volume":"10","author":"Nyholm","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0125","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","article-title":"Pramlintide in the treatment of type 1 and type 2 diabetes mellitus","volume":"27","author":"Ryan","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450053174596","article-title":"Pancreatic amylin as a centrally acting satiating hormone","volume":"6","author":"Lutz","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2014.01.013","article-title":"Amylin activates distributed CNS nuclei to control energy balance","volume":"136","author":"Mietlicki-Baase","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0140","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/endo.138.10.5264","article-title":"Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique","volume":"138","author":"Arnelo","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0150","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2013.47","article-title":"Emerging combinatorial hormone therapies for the treatment of obesity and T2DM","volume":"9","author":"Sadry","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","article-title":"Amylin and the regulation of appetite and adiposity: recent advances in receptor signaling, neurobiology and pharmacology","volume":"20","author":"Roth","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnins.2015.00216","article-title":"Amylin at the interface between metabolic and neurodegenerative disorders","volume":"9","author":"Lutz","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0170","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1523\/JNEUROSCI.2260-13.2014","article-title":"Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression","volume":"34","author":"Baisley","year":"2014","journal-title":"J Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","article-title":"Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?","volume":"6","author":"Qiu","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2015.09.004","article-title":"Molecular aspects of glucose homeostasis in skeletal muscle \u2014 a focus on the molecular mechanisms of insulin resistance","volume":"417","author":"Carnagarin","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF01925572","article-title":"Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat","volume":"52","author":"Clementi","year":"1996","journal-title":"Experientia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","article-title":"Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake","volume":"45","author":"Young","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0195","doi-asserted-by":"crossref","first-page":"R605","DOI":"10.1152\/ajpregu.2001.280.3.R605","article-title":"Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats","volume":"280","author":"Reidelberger","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2008.03.010","article-title":"Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy","volume":"148","author":"Wickbom","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0205","first-page":"R1279","article-title":"Selective vagal rhizotomies: a new dorsal surgical approach used for intestinal deafferentations","volume":"269","author":"Walls","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0196-9781(97)00292-1","article-title":"Lesion of the area postrema\/nucleus of the solitary tract (AP\/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","article-title":"Inhibition of gastric emptying","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0149-7634(95)00040-L","article-title":"Vagal control of digestion: modulation by central neural and peripheral endocrine factors","volume":"20","author":"Rogers","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.physiol.68.040504.094635","article-title":"Brainstem circuits regulating gastric function","volume":"68","author":"Travagli","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cne.902340306","article-title":"The central neural connections of the area postrema of the rat","volume":"234","author":"Shapiro","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0235","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis","volume":"286","author":"Riediger","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0240","first-page":"R1131","article-title":"Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius","volume":"259","author":"Gross","year":"1990","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(96)00282-X","article-title":"Synaptic connections and interactions between area postrema and nucleus tractus solitarius","volume":"724","author":"Cai","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1113\/expphysiol.1995.sp003839","article-title":"Glutamate-immunoreactivity in identified vagal afferent terminals of the cat: a study combining horseradish peroxidase tracing and postembedding electron microscopic immunogold staining","volume":"80","author":"Saha","year":"1995","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0255","first-page":"H1307","article-title":"Non-NMDA receptors mediate sensory afferent synaptic transmission in medial nucleus tractus solitarius","volume":"259","author":"Andresen","year":"1990","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0260","first-page":"R1436","article-title":"Vagal afferent transmission in the NTS mediating reflex responses of the rat esophagus","volume":"274","author":"Lu","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0265","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2004.05.049","article-title":"Excitatory and inhibitory local circuit input to the rat dorsal motor nucleus of the vagus originating from the nucleus tractus solitarius","volume":"1017","author":"Davis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0270","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0275","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/jme.0.003R001","article-title":"Expression of the rat amylin (IAPP\/DAP) gene","volume":"3","author":"Ferrier","year":"1989","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/jme.0.0090157","article-title":"Extra-pancreatic expression of the rat islet amyloid polypeptide (amylin) gene","volume":"9","author":"Nicholl","year":"1992","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0285","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-291X(05)81416-0","article-title":"Identification and characterization of islet amyloid polypeptide in mammalian gastrointestinal tract","volume":"181","author":"Miyazato","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0290","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bbrc.2014.07.140","article-title":"Distribution of insulin mRNA transcripts within the human body","volume":"451","author":"Bell","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0295","first-page":"906","article-title":"Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes","volume":"130","author":"Bhogal","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0196-9781(97)00008-9","article-title":"Islet amyloid polypeptide in the gut and pancreas: localization, ontogeny and gut motility effects","volume":"18","author":"Mulder","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0305","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-291X(90)90400-H","article-title":"Regional distribution and molecular forms of rat islet amyloid polypeptide","volume":"169","author":"Asai","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0310","first-page":"R609","article-title":"Gastric emptying of glucose loads in rats: effects of insulin-induced hypoglycemia","volume":"251","author":"McCann","year":"1986","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0315","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/diacare.18.5.674","article-title":"Hypoglycemia increases the gastric emptying rate in healthy subjects","volume":"18","author":"Schvarcz","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diab.47.1.93","article-title":"Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats","volume":"47","author":"Gedulin","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00482-2","article-title":"Amylin and glucose co-activate area postrema neurons of the rat","volume":"328","author":"Riediger","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0330","doi-asserted-by":"crossref","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","article-title":"Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP","volume":"281","author":"Riediger","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0335","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/0006-291X(90)90636-2","article-title":"Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas","volume":"167","author":"Fehmann","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dmr.5610030108","article-title":"Mechanisms of hormonal regulation of hepatic glucose metabolism","volume":"3","author":"Exton","year":"1987","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0345","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0140-6736(90)90966-9","article-title":"Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus","volume":"335","author":"Hartter","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00198-003-1538-5","article-title":"Amylin fasting plasma levels are decreased in patients with osteoporosis","volume":"15","author":"Bronsky","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0355","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective","author":"Zaccardi","year":"2015","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0360","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0365","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/isl.3.4.15875","article-title":"Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects","volume":"3","author":"Tomita","year":"2011","journal-title":"Islets"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0370","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.40.12.1701","article-title":"Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats","volume":"40","author":"O'Brien","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(91)91325-7","article-title":"Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents","volume":"179","author":"Moore","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","article-title":"Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans","volume":"34","author":"Hartter","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0385","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diacare.25.2.292","article-title":"Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes","volume":"25","author":"Knowles","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1677\/jme.0.0060003","article-title":"Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat","volume":"6","author":"Bretherton-Watt","year":"1991","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0395","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00403322","article-title":"Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians","volume":"33","author":"Clark","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0400","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","article-title":"Amylin concentrations and glucose control","volume":"339","author":"Koda","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0405","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/clinchem\/42.4.576","article-title":"Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma","volume":"42","author":"Percy","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0410","first-page":"245","article-title":"Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells","volume":"135","author":"Johnson","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","article-title":"Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"15","author":"Enoki","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0420","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0306-9877(91)90150-W","article-title":"Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus","volume":"36","author":"Cooper","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0425","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0430","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","article-title":"Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue","volume":"18","author":"Kolterman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0435","first-page":"S34","article-title":"Modulation of gastric emptying as a therapeutic approach to glycaemic control","volume":"13","author":"Moyses","year":"1996","journal-title":"Diabet. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0440","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","article-title":"Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus","volume":"183","author":"Betsholtz","year":"1989","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0445","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0450","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0455","first-page":"24","article-title":"What's new in clinical pharmacology and therapeutics","volume":"105","author":"Chawla","year":"2006","journal-title":"WMJ"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0460","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajhp\/62.8.816","article-title":"Properties of pramlintide and insulin upon mixing","volume":"62","author":"Weyer","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0465","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0470","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0475","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0480","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2982.2002.00311.x","article-title":"Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus","volume":"14","author":"Vella","year":"2002","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0490","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0495","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0500","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0505","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc06-1026","article-title":"Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes","volume":"30","author":"Marrero","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0510","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1463-1326.2010.01337.x","article-title":"The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis","volume":"13","author":"Singh-Franco","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0515","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1370\/afm.1174","article-title":"Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus","volume":"8","author":"Lee","year":"2010","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0520","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0525","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/vhrm.2006.2.3.203","article-title":"Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes","volume":"2","author":"Pullman","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0530","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jps.21197","article-title":"A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams","volume":"97","author":"Nonoyama","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0535","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1021\/bi500592p","article-title":"Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubility","volume":"53","author":"Wang","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0540","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2007-978923","article-title":"Nephrectomy decreases amylin and pramlintide clearance in rats","volume":"30","author":"Vine","year":"1998","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0545","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0550","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI117103","article-title":"Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors","volume":"93","author":"Bondy","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0555","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13297","article-title":"Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones","volume":"511","author":"Maianti","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0560","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2014.07.016","article-title":"Insulin-degrading enzyme inhibition, a novel therapy for type 2 diabetes?","volume":"20","author":"Costes","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0565","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0570","first-page":"R1654","article-title":"Chronic infusion of islet amyloid polypeptide causes anorexia in rats","volume":"271","author":"Arnelo","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0575","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0580","first-page":"R178","article-title":"Modulation of food intake by peripherally administered amylin","volume":"267","author":"Morley","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0585","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/endo.141.2.7378","article-title":"Amylin: a novel action in the brain to reduce body weight","volume":"141","author":"Rushing","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0590","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0196-9781(02)00022-0","article-title":"Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences","volume":"23","author":"Rushing","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0595","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0196-9781(94)00203-I","article-title":"Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin","volume":"16","author":"Lutz","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0600","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2007.02.012","article-title":"The acute effect of amylin and salmon calcitonin on energy expenditure","volume":"91","author":"Wielinga","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2010.04.012","article-title":"Central amylin acts as an adiposity signal to control body weight and energy expenditure","volume":"101","author":"Wielinga","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0610","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.physbeh.2004.01.006","article-title":"Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats","volume":"81","author":"Mollet","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0615","doi-asserted-by":"crossref","first-page":"R623","DOI":"10.1152\/ajpregu.00791.2009","article-title":"Noradrenergic neurons of the area postrema mediate amylin's hypophagic action","volume":"299","author":"Potes","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0620","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/ejn.12672","article-title":"The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping","volume":"40","author":"Braegger","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0625","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0630","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-24716-3_10","article-title":"Effects of amylin on eating and adiposity","volume":"231-50","author":"Lutz","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0635","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2011.02.015","article-title":"Amylinergic control of food intake in lean and obese rodents","volume":"105","author":"Boyle","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0640","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13212-4","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0645","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0650","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jchemneu.2004.03.005","article-title":"In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain","volume":"27","author":"Paxinos","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0655","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0660","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/frne.2001.0224","article-title":"The neuroanatomical axis for control of energy balance","volume":"23","author":"Grill","year":"2002","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0665","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0670","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0675","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tips.2013.11.003","article-title":"Feelings about food: the ventral tegmental area in food reward and emotional eating","volume":"35","author":"Meye","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0680","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1017\/S1092852915000693","article-title":"Mesolimbic dopamine and its neuromodulators in obesity and binge eating","volume":"20","author":"Naef","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0685","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yfrne.2009.10.004","article-title":"Metabolic hormones, dopamine circuits, and feeding","volume":"31","author":"Narayanan","year":"2010","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0690","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0695","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0700","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2011.02.016","article-title":"Ghrelin directly targets the ventral tegmental area to increase food motivation","volume":"180","author":"Skibicka","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0705","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2006.08.023","article-title":"Leptin receptor signaling in midbrain dopamine neurons regulates feeding","volume":"51","author":"Hommel","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0710","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbr.2011.01.020","article-title":"Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats","volume":"219","author":"Bruijnzeel","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0715","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/npp.2013.66","article-title":"Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake","volume":"38","author":"Mietlicki-Baase","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0720","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/npp.2014.180","article-title":"Amylin modulates the mesolimbic dopamine system to control energy balance","volume":"40","author":"Mietlicki-Baase","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0725","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1152\/ajpendo.00087.2015","article-title":"Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake","volume":"308","author":"Mietlicki-Baase","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0730","doi-asserted-by":"crossref","first-page":"R1232","DOI":"10.1152\/ajpregu.2001.281.4.R1232","article-title":"Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior","volume":"281","author":"Baldo","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0735","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/npp.2014.153","article-title":"Amylin receptor signaling in the nucleus accumbens negatively modulates mu-opioid-driven feeding","volume":"39","author":"Baisley","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0740","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.2009.06422.x","article-title":"Central amylin expression and its induction in rat dams","volume":"111","author":"Dobolyi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0745","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1096\/fj.11-191841","article-title":"Amylin is a novel neuropeptide with potential maternal functions in the rat","volume":"26","author":"Szabo","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0750","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2010.03.114","article-title":"Identification of central projections from amylin-activated neurons to the lateral hypothalamus","volume":"1334","author":"Potes","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0755","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1113\/jphysiol.2012.243493","article-title":"Lateral hypothalamic GAD65 neurons are spontaneously firing and distinct from orexin- and melanin-concentrating hormone neurons","volume":"591","author":"Karnani","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0760","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/oby.2007.626","article-title":"Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects","volume":"15","author":"Chapman","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0765","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0770","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0196-9781(99)00139-4","article-title":"Impaired transport of leptin across the blood-brain barrier in obesity","volume":"20","author":"Banks","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0775","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1210\/en.2004-0726","article-title":"Region-specific leptin resistance within the hypothalamus of diet-induced obese mice","volume":"145","author":"Munzberg","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0780","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0785","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","article-title":"Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study","volume":"293","author":"Smith","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0790","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0795","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0800","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0805","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0810","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","article-title":"Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients","volume":"12","author":"Hollander","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0815","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","article-title":"Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity","volume":"148","author":"Roth","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0820","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-978590","article-title":"Amylin and insulin interact to reduce food intake in rats","volume":"32","author":"Rushing","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0825","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0830","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1210\/en.2008-0770","article-title":"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms","volume":"149","author":"Trevaskis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0835","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/oby.2009.187","article-title":"Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats","volume":"18","author":"Trevaskis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0840","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2010.03.006","article-title":"Insights into amylin-leptin synergy","volume":"21","author":"Trevaskis","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0845","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylin\/leptin synergy in rodent models","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0850","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2310\/JIM.0b013e3181b91911","article-title":"It takes two to tango: combined amylin\/leptin agonism as a potential approach to obesity drug development","volume":"57","author":"Chan","year":"2009","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0855","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ijo.2010.262","article-title":"Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats","volume":"35","author":"Seth","year":"2011","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0860","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0865","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-011-2332-0","article-title":"Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C(2)C(1)(2) muscle and AML12 liver cell lines","volume":"55","author":"Moon","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0870","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00125-012-2799-3","article-title":"Amylin-induced downregulation of hippocampal neurogenesis is attenuated by leptin in a STAT3\/AMPK\/ERK-dependent manner in mice","volume":"56","author":"Moon","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0875","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/db14-0645","article-title":"Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling","volume":"64","author":"Le Foll","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0880","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/endo.139.1.5685","article-title":"Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain","volume":"139","author":"Mercer","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0885","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2","article-title":"Distributions of leptin receptor mRNA isoforms in the rat brain","volume":"395","author":"Elmquist","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0890","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2010.07.094","article-title":"Co-localization of TRHR1 and LepRb receptors on neurons in the hindbrain of the rat","volume":"1355","author":"Barnes","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0895","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.13163","article-title":"Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons","author":"Liberini","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0900","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11695-012-0634-z","article-title":"A review of unmet needs in obesity management","volume":"22","author":"Nguyen","year":"2012","journal-title":"Obes. Surg."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0905","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.physbeh.2010.02.023","article-title":"Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?","volume":"100","author":"Trevaskis","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0910","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2012.01670.x","article-title":"The interaction of amylin with other hormones in the control of eating","volume":"15","author":"Lutz","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0915","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0920","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1467-789X.2008.00473.x","article-title":"Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis","volume":"9","author":"Beydoun","year":"2008","journal-title":"Obes. Rev."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0925","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jgs.13441","article-title":"Relationship between type 2 diabetes mellitus and cognitive change in a multiethnic elderly cohort","volume":"63","author":"Bangen","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0930","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/CIA.S48926","article-title":"Type 2 diabetes as a risk factor for cognitive impairment: current insights","volume":"9","author":"Umegaki","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0935","article-title":"Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0940","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1567205012666150710115506","article-title":"Insulin resistance as common molecular denominator linking obesity to Alzheimer's disease","volume":"12","author":"Nuzzo","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0945","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.3","article-title":"Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome","volume":"47","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0950","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/db12-0866","article-title":"Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice","volume":"62","author":"Leboucher","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0955","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14789450.2015.1104251","article-title":"Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes","volume":"12","author":"Ly","year":"2015","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0960","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0965","article-title":"Plasma amylin and cognition in diabetes in the absence and the presence of insulin treatment","volume":"5","author":"Qiu","year":"2014","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0970","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0975","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nlm.2011.01.004","article-title":"Bidirectional metabolic regulation of neurocognitive function","volume":"96","author":"Stranahan","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"issue":"Suppl. 2","key":"10.1016\/j.physbeh.2016.02.034_bb0980","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-2011-110899","article-title":"Metabolic reserve as a determinant of cognitive aging","volume":"30","author":"Stranahan","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0985","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000026432","article-title":"Human amylin stimulates inflammatory cytokine secretion from human glioma cells","volume":"7","author":"Gitter","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.physbeh.2016.02.034_bb0990","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fnins.2015.00259","article-title":"Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes","volume":"9","author":"Steardo","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb0995","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1000","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2174\/1871527313666140917095514","article-title":"Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Ashraf","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JAD-140018","article-title":"The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease","volume":"42","author":"Desai","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"Beta-amyloid: the key peptide in the pathogenesis of Alzheimer's disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1030","first-page":"646","article-title":"Exogenous amyloidogenic proteins function as seeds in amyloid beta-protein aggregation","volume":"2014","author":"Ono","year":"1842","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1035","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","article-title":"Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor","volume":"32","author":"Kimura","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","article-title":"Actions of beta-amyloid protein on human neurons are expressed through the amylin receptor","volume":"178","author":"Jhamandas","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10495-011-0656-3","article-title":"Beta-amyloid protein (Abeta) and human amylin regulation of apoptotic genes occurs through the amylin receptor","volume":"17","author":"Jhamandas","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1050","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.1051-04.2004","article-title":"Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons","volume":"24","author":"Jhamandas","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1055","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","article-title":"Activity of pramlintide, rat and human amylin but not Abeta1\u201342 at human amylin receptors","volume":"155","author":"Gingell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-140210","article-title":"Positive association between plasma amylin and cognition in a homebound elderly population","volume":"42","author":"Qiu","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1075","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures","volume":"582","author":"Lim","year":"2008","journal-title":"FEBS Lett."},{"issue":"Suppl","key":"10.1016\/j.physbeh.2016.02.034_bb1080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcb.240550006","article-title":"Molecular physiology of the islet amyloid polypeptide (IAPP)\/amylin gene in man, rat, and transgenic mice","volume":"55","author":"Hoppener","year":"1994","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00400272","article-title":"Sequences of islet amyloid polypeptide precursors of an Old World monkey, the pig-tailed macaque (Macaca nemestrina), and the dog (Canis familiaris)","volume":"34","author":"Ohagi","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/diacare.39.1.118","article-title":"Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation","volume":"39","author":"Betsholtz","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1095","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0006-291X(90)90359-U","article-title":"Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes","volume":"169","author":"Jordan","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","article-title":"Prepulse inhibition in psychiatric disorders\u2013apart from schizophrenia","volume":"47","author":"Kohl","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02246437","article-title":"Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs","volume":"122","author":"Varty","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430230110","article-title":"Prepulse inhibition as a screening tool for potential antipsychotics","volume":"23","author":"Rigdon","year":"1991","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.yhbeh.2011.08.006","article-title":"Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area","volume":"60","author":"King","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.psyneuen.2015.09.009","article-title":"Ghrelin and GHS-R1A signaling within the ventral and laterodorsal tegmental area regulate sexual behavior in sexually naive male mice","volume":"62","author":"Prieto-Garcia","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1135","article-title":"The stomach-derived hormone ghrelin increases impulsive behavior","author":"Anderberg","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2016.02.034_bb1140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.suc.2011.08.001","article-title":"Epidemiology and economic impact of obesity and type 2 diabetes","volume":"91","author":"Shamseddeen","year":"2011","journal-title":"Surg. Clin. N. Am."},{"key":"10.1016\/j.physbeh.2016.02.034_bb1145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TCRM.S1458","article-title":"Factors affecting therapeutic compliance: a review from the patient's perspective","volume":"4","author":"Jin","year":"2008","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938416300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938416300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:18:00Z","timestamp":1748791080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938416300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":229,"alternative-id":["S0031938416300786"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2016.02.034","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amylin-mediated control of glycemia, energy balance, and cognition","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2016.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}